Evidence map›Paper›PMID 20562530›Full record

ArticleCell adhesion & migration

Sweet cues: How heparan sulfate modification of fibronectin enables growth factor guided migration of embryonic cells.

Karen Symes, Erin M Smith, Maria Mitsi, Matthew A Nugent

Open access · goldAbstract read
In one paragraph

Article in Cell adhesion & migration. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Glycosaminoglycans as Polyelectrolytes: Charge, Interactions, and Applications.Chembiochem : a European journal of chemical biology · 2025
    Review
  2. Article
  3. Review
  4. Heparin-dependent regulation of fibronectin matrix conformation.Matrix biology : journal of the International Society for Matrix Biology · 2014
    Article
  5. Review
  6. Article
  7. Heparan sulfate proteoglycans.Cold Spring Harbor perspectives in biology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Karen SymesDepartment of Biochemistry, Boston University School of Medicine; Boston, MA, USA. symes@bu.edu
Erin M Smith
Maria Mitsi
Matthew A Nugent
Boston University · USETH Zurich · CH

Funding

Growth Factors in Vascular BiologyR01HL056200 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI NUGENT, MATTHEW A · 1997 to 2008
$2.7M
Elastase Injury of Pulmonary Extracellular MatrixR01HL088572 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI NUGENT, MATTHEW A · 2008 to 2012
$2.0M
CELL MOVEMENT DURING XENOPUS DEVELOPMENT--METASTASISR01CA087375 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI SYMES, KAREN · 2000 to 2004
$1.3M
NCI NIH HHS CA87375NCI NIH HHS R01 CA087375NHLBI NIH HHS HL056200NHLBI NIH HHS HL088572NHLBI NIH HHS R01 HL056200NHLBI NIH HHS R01 HL088572
6 · The paper itself

Abstract

Growth factors regulate a diverse array of cellular functions including proliferation, survival, movement, and the ability to do this often involves interactions with the extracellular matrix (ECM) and particularly heparan sulfate proteoglycans (HSPGs). HSPGs have been shown to sequester growth factors, and to act as growth factor co-receptors or receptors themselves. Recent studies, however, have revealed a new role for HSPGs in mediating the interactions of growth factors with the ECM. Specifically, heparan sulfate has been shown to modulate fibronectin structure to reveal previously masked growth factor binding sites. In vivo, this mechanism appears to control the guidance of migrating cells during embryonic development as HSPG-modification of fibronectin enables direct platelet derived growth factor-fibronectin interactions necessary for this process. A model based on this observation is discussed here as well as the possibility that other growth factors/morphogens utilize similar mechanisms involving fibronectin or additional ECM proteins.

Indexed as

Embryonic DevelopmentAnimalsCell MovementExtracellular MatrixFibronectinsHeparan Sulfate ProteoglycansHumansPlatelet-Derived Growth FactorProtein ConformationSignal TransductionVascular Endothelial Growth Factor AFibronectinsHeparan Sulfate ProteoglycansPlatelet-Derived Growth FactorVascular Endothelial Growth Factor A

Identifiers

PMID20562530
PMCPMC3011263
OpenAlexW2074366191

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.